| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription coregulator activity | 1.89e-04 | 562 | 20 | 5 | GO:0003712 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | 7.26e-04 | 1160 | 20 | 6 | GO:0030674 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | 1.64e-03 | 1356 | 20 | 6 | GO:0060090 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | 2.39e-03 | 582 | 20 | 4 | GO:0140297 | |
| GeneOntologyMolecularFunction | mRNA 3'-UTR binding | 2.50e-03 | 276 | 20 | 3 | GO:0003730 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | 3.26e-03 | 303 | 20 | 3 | GO:0003713 | |
| GeneOntologyMolecularFunction | syntaxin binding | 3.39e-03 | 87 | 20 | 2 | GO:0019905 | |
| GeneOntologyMolecularFunction | mRNA binding | 4.49e-03 | 694 | 20 | 4 | GO:0003729 | |
| GeneOntologyMolecularFunction | single-stranded RNA binding | 5.45e-03 | 111 | 20 | 2 | GO:0003727 | |
| GeneOntologyMolecularFunction | transcription factor binding | 6.00e-03 | 753 | 20 | 4 | GO:0008134 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 7.92e-03 | 417 | 20 | 3 | GO:0061629 | |
| GeneOntologyMolecularFunction | SNARE binding | 8.07e-03 | 136 | 20 | 2 | GO:0000149 | |
| GeneOntologyMolecularFunction | protein domain specific binding | 1.01e-02 | 875 | 20 | 4 | GO:0019904 | |
| GeneOntologyBiologicalProcess | placenta development | 3.47e-05 | 197 | 20 | 4 | GO:0001890 | |
| GeneOntologyBiologicalProcess | vesicle fusion with Golgi apparatus | 4.00e-05 | 10 | 20 | 2 | GO:0048280 | |
| GeneOntologyCellularComponent | npBAF complex | 7.86e-05 | 14 | 20 | 2 | GO:0071564 | |
| GeneOntologyCellularComponent | SWI/SNF complex | 3.72e-04 | 30 | 20 | 2 | GO:0016514 | |
| GeneOntologyCellularComponent | presynaptic cytosol | 9.95e-04 | 49 | 20 | 2 | GO:0099523 | |
| Domain | RRM_1 | 2.21e-06 | 208 | 20 | 5 | PF00076 | |
| Domain | RRM | 2.72e-06 | 217 | 20 | 5 | SM00360 | |
| Domain | RRM_dom | 3.39e-06 | 227 | 20 | 5 | IPR000504 | |
| Domain | RRM | 3.62e-06 | 230 | 20 | 5 | PS50102 | |
| Domain | - | 4.82e-06 | 244 | 20 | 5 | 3.30.70.330 | |
| Domain | Nucleotide-bd_a/b_plait | 6.33e-06 | 258 | 20 | 5 | IPR012677 | |
| Domain | - | 4.88e-05 | 10 | 20 | 2 | 4.10.1060.10 | |
| Domain | zf-RanBP | 2.48e-04 | 22 | 20 | 2 | PF00641 | |
| Domain | ZnF_RBZ | 2.72e-04 | 23 | 20 | 2 | SM00547 | |
| Domain | ZF_RANBP2_2 | 2.72e-04 | 23 | 20 | 2 | PS50199 | |
| Domain | ZF_RANBP2_1 | 2.96e-04 | 24 | 20 | 2 | PS01358 | |
| Domain | Znf_RanBP2 | 3.22e-04 | 25 | 20 | 2 | IPR001876 | |
| Pathway | WP_MRNA_PROCESSING | 1.07e-04 | 451 | 16 | 5 | MM15946 | |
| Pubmed | FET family fusion oncoproteins target the SWI/SNF chromatin remodeling complex. | 6.99e-10 | 23 | 20 | 4 | 30962207 | |
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | 4.66e-09 | 462 | 20 | 7 | 31138677 | |
| Pubmed | 1.58e-08 | 552 | 20 | 7 | 36293380 | ||
| Pubmed | 1.95e-08 | 10 | 20 | 3 | 21956701 | ||
| Pubmed | 1.95e-08 | 51 | 20 | 4 | 26269332 | ||
| Pubmed | WW domains provide a platform for the assembly of multiprotein networks. | 2.34e-08 | 154 | 20 | 5 | 16055720 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 2.93e-08 | 954 | 20 | 8 | 36373674 | |
| Pubmed | 6.87e-08 | 191 | 20 | 5 | 24146773 | ||
| Pubmed | 1.57e-07 | 453 | 20 | 6 | 29656893 | ||
| Pubmed | 2.32e-07 | 244 | 20 | 5 | 29884807 | ||
| Pubmed | 2.49e-07 | 22 | 20 | 3 | 12456657 | ||
| Pubmed | 3.14e-07 | 2 | 20 | 2 | 31392992 | ||
| Pubmed | 3.14e-07 | 2 | 20 | 2 | 20660338 | ||
| Pubmed | 3.14e-07 | 2 | 20 | 2 | 8921363 | ||
| Pubmed | 3.14e-07 | 2 | 20 | 2 | 26573619 | ||
| Pubmed | 3.14e-07 | 2 | 20 | 2 | 31994243 | ||
| Pubmed | Identifying and quantifying in vivo methylation sites by heavy methyl SILAC. | 6.54e-07 | 30 | 20 | 3 | 15782174 | |
| Pubmed | Novel FUS-KLF17 and EWSR1-KLF17 fusions in myoepithelial tumors. | 9.42e-07 | 3 | 20 | 2 | 25706482 | |
| Pubmed | FUS-NFATC2 or EWSR1-NFATC2 Fusions Are Present in a Large Proportion of Simple Bone Cysts. | 9.42e-07 | 3 | 20 | 2 | 32991339 | |
| Pubmed | 9.42e-07 | 3 | 20 | 2 | 26690869 | ||
| Pubmed | 9.42e-07 | 3 | 20 | 2 | 34049318 | ||
| Pubmed | 9.42e-07 | 3 | 20 | 2 | 18620564 | ||
| Pubmed | 9.42e-07 | 3 | 20 | 2 | 27903134 | ||
| Pubmed | mRNA and protein levels of FUS, EWSR1, and TAF15 are upregulated in liposarcoma. | 9.42e-07 | 3 | 20 | 2 | 21344536 | |
| Pubmed | Characterization of a new brain-specific isoform of the EWS oncoprotein. | 9.42e-07 | 3 | 20 | 2 | 11422378 | |
| Pubmed | 9.42e-07 | 3 | 20 | 2 | 38168093 | ||
| Pubmed | 9.42e-07 | 3 | 20 | 2 | 23975937 | ||
| Pubmed | 9.42e-07 | 3 | 20 | 2 | 28505004 | ||
| Pubmed | 9.42e-07 | 3 | 20 | 2 | 23049996 | ||
| Pubmed | Aggregation of FET Proteins as a Pathological Change in Amyotrophic Lateral Sclerosis. | 9.42e-07 | 3 | 20 | 2 | 27311318 | |
| Pubmed | 9.42e-07 | 3 | 20 | 2 | 21856723 | ||
| Pubmed | 9.42e-07 | 3 | 20 | 2 | 33859361 | ||
| Pubmed | 9.42e-07 | 3 | 20 | 2 | 27415968 | ||
| Pubmed | ARIH2 Is a Vif-Dependent Regulator of CUL5-Mediated APOBEC3G Degradation in HIV Infection. | 1.12e-06 | 336 | 20 | 5 | 31253590 | |
| Pubmed | 1.19e-06 | 340 | 20 | 5 | 24332808 | ||
| Pubmed | 1.32e-06 | 347 | 20 | 5 | 16033648 | ||
| Pubmed | Genetic Screens Reveal FEN1 and APEX2 as BRCA2 Synthetic Lethal Targets. | 1.83e-06 | 157 | 20 | 4 | 30686591 | |
| Pubmed | 1.88e-06 | 4 | 20 | 2 | 28453628 | ||
| Pubmed | The neurodegenerative diseases ALS and SMA are linked at the molecular level via the ASC-1 complex. | 1.88e-06 | 4 | 20 | 2 | 30398641 | |
| Pubmed | 1.88e-06 | 4 | 20 | 2 | 9660765 | ||
| Pubmed | Characterization of TFG in mus musculus and Caenorhabditis elegans. | 1.88e-06 | 4 | 20 | 2 | 10092511 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | 2.32e-06 | 1155 | 20 | 7 | 20360068 | |
| Pubmed | 2.63e-06 | 172 | 20 | 4 | 26336360 | ||
| Pubmed | 3.14e-06 | 5 | 20 | 2 | 38279469 | ||
| Pubmed | IGF1 is a common target gene of Ewing's sarcoma fusion proteins in mesenchymal progenitor cells. | 3.14e-06 | 5 | 20 | 2 | 18648544 | |
| Pubmed | 3.39e-06 | 421 | 20 | 5 | 34650049 | ||
| Pubmed | 3.55e-06 | 425 | 20 | 5 | 24999758 | ||
| Pubmed | 3.96e-06 | 54 | 20 | 3 | 18495661 | ||
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | 4.06e-06 | 1257 | 20 | 7 | 37317656 | |
| Pubmed | Induced ncRNAs allosterically modify RNA-binding proteins in cis to inhibit transcription. | 4.71e-06 | 6 | 20 | 2 | 18509338 | |
| Pubmed | 4.71e-06 | 6 | 20 | 2 | 21954064 | ||
| Pubmed | 4.71e-06 | 6 | 20 | 2 | 30354839 | ||
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | 5.05e-06 | 457 | 20 | 5 | 32344865 | |
| Pubmed | 5.38e-06 | 206 | 20 | 4 | 22174317 | ||
| Pubmed | 5.81e-06 | 844 | 20 | 6 | 25963833 | ||
| Pubmed | 6.48e-06 | 216 | 20 | 4 | 37640791 | ||
| Pubmed | 6.59e-06 | 7 | 20 | 2 | 17959791 | ||
| Pubmed | 6.59e-06 | 7 | 20 | 2 | 23540691 | ||
| Pubmed | 6.94e-06 | 65 | 20 | 3 | 26655900 | ||
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 6.97e-06 | 220 | 20 | 4 | 35785414 | |
| Pubmed | The RNA-binding protein HuR is a novel target of Pirh2 E3 ubiquitin ligase. | 6.97e-06 | 220 | 20 | 4 | 34091597 | |
| Pubmed | 9.19e-06 | 236 | 20 | 4 | 36339263 | ||
| Pubmed | 1.03e-05 | 74 | 20 | 3 | 33989516 | ||
| Pubmed | 1.07e-05 | 245 | 20 | 4 | 21182205 | ||
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | 1.13e-05 | 949 | 20 | 6 | 36574265 | |
| Pubmed | 1.25e-05 | 551 | 20 | 5 | 34728620 | ||
| Pubmed | Perturbation of the mutated EGFR interactome identifies vulnerabilities and resistance mechanisms. | 1.27e-05 | 256 | 20 | 4 | 24189400 | |
| Pubmed | SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9. | 1.31e-05 | 258 | 20 | 4 | 37794589 | |
| Pubmed | 1.35e-05 | 260 | 20 | 4 | 36199071 | ||
| Pubmed | ABHD4-dependent developmental anoikis safeguards the embryonic brain. | 1.41e-05 | 10 | 20 | 2 | 32868797 | |
| Pubmed | TDRD3, a novel Tudor domain-containing protein, localizes to cytoplasmic stress granules. | 1.41e-05 | 10 | 20 | 2 | 18632687 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | 1.43e-05 | 989 | 20 | 6 | 36424410 | |
| Pubmed | 1.59e-05 | 1007 | 20 | 6 | 34597346 | ||
| Pubmed | 1.65e-05 | 274 | 20 | 4 | 34244482 | ||
| Pubmed | 1.72e-05 | 11 | 20 | 2 | 33469008 | ||
| Pubmed | 1.73e-05 | 88 | 20 | 3 | 26318153 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | 1.75e-05 | 1024 | 20 | 6 | 24711643 | |
| Pubmed | 1.85e-05 | 90 | 20 | 3 | 23151878 | ||
| Pubmed | Histone-binding of DPF2 mediates its repressive role in myeloid differentiation. | 1.88e-05 | 283 | 20 | 4 | 28533407 | |
| Pubmed | 2.07e-05 | 12 | 20 | 2 | 11734557 | ||
| Pubmed | 2.66e-05 | 1103 | 20 | 6 | 34189442 | ||
| Pubmed | 3.28e-05 | 15 | 20 | 2 | 23785148 | ||
| Pubmed | Lysosomal Signaling Licenses Embryonic Stem Cell Differentiation via Inactivation of Tfe3. | 3.50e-05 | 332 | 20 | 4 | 30595499 | |
| Pubmed | Pluripotency factors regulate definitive endoderm specification through eomesodermin. | 3.75e-05 | 16 | 20 | 2 | 21245162 | |
| Pubmed | 3.75e-05 | 16 | 20 | 2 | 31515109 | ||
| Pubmed | 3.75e-05 | 16 | 20 | 2 | 29507213 | ||
| Pubmed | 3.75e-05 | 16 | 20 | 2 | 24633704 | ||
| Pubmed | 3.75e-05 | 16 | 20 | 2 | 22745484 | ||
| Pubmed | 3.85e-05 | 115 | 20 | 3 | 17332742 | ||
| Pubmed | ATG5 is required for B cell polarization and presentation of particulate antigens. | 3.96e-05 | 701 | 20 | 5 | 30196744 | |
| Pubmed | Mutual regulation between OGT and XIAP to control colon cancer cell growth and invasion. | 4.04e-05 | 704 | 20 | 5 | 32994395 | |
| Pubmed | 4.11e-05 | 346 | 20 | 4 | 25324306 | ||
| Pubmed | Defective neurite elongation and branching in Nibp/Trappc9 deficient zebrafish and mice. | 4.25e-05 | 17 | 20 | 2 | 37416774 | |
| Pubmed | 4.48e-05 | 121 | 20 | 3 | 34029587 | ||
| Pubmed | 4.60e-05 | 122 | 20 | 3 | 29530978 | ||
| Pubmed | 4.64e-05 | 725 | 20 | 5 | 27025967 | ||
| Pubmed | 4.78e-05 | 18 | 20 | 2 | 27618312 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | 5.52e-05 | 1257 | 20 | 6 | 36526897 | |
| Pubmed | 5.68e-05 | 131 | 20 | 3 | 34551306 | ||
| Pubmed | Identification of 14-3-3epsilon substrates from embryonic murine brain. | 5.81e-05 | 132 | 20 | 3 | 16944949 | |
| Interaction | FLI1 interactions | 3.79e-07 | 62 | 20 | 4 | int:FLI1 | |
| Interaction | RCHY1 interactions | 5.38e-07 | 325 | 20 | 6 | int:RCHY1 | |
| Interaction | NEDD8 interactions | 1.63e-06 | 393 | 20 | 6 | int:NEDD8 | |
| Interaction | TAF15 interactions | 2.02e-06 | 408 | 20 | 6 | int:TAF15 | |
| Interaction | RARA interactions | 2.15e-06 | 223 | 20 | 5 | int:RARA | |
| Interaction | NUP35 interactions | 2.53e-06 | 424 | 20 | 6 | int:NUP35 | |
| Interaction | SMC5 interactions | 2.64e-06 | 1000 | 20 | 8 | int:SMC5 | |
| Interaction | SMARCA4 interactions | 4.15e-06 | 462 | 20 | 6 | int:SMARCA4 | |
| Interaction | DDIT3 interactions | 5.38e-06 | 120 | 20 | 4 | int:DDIT3 | |
| Interaction | CELF1 interactions | 7.49e-06 | 288 | 20 | 5 | int:CELF1 | |
| Interaction | TP53BP1 interactions | 9.40e-06 | 533 | 20 | 6 | int:TP53BP1 | |
| Interaction | ARIH2 interactions | 1.14e-05 | 314 | 20 | 5 | int:ARIH2 | |
| Interaction | CUL1 interactions | 1.35e-05 | 876 | 20 | 7 | int:CUL1 | |
| Interaction | CUL2 interactions | 1.69e-05 | 591 | 20 | 6 | int:CUL2 | |
| Interaction | HNRNPDL interactions | 2.32e-05 | 364 | 20 | 5 | int:HNRNPDL | |
| Interaction | SNRNP40 interactions | 2.58e-05 | 637 | 20 | 6 | int:SNRNP40 | |
| Interaction | MYCN interactions | 2.73e-05 | 1373 | 20 | 8 | int:MYCN | |
| Interaction | USP48 interactions | 3.38e-05 | 668 | 20 | 6 | int:USP48 | |
| Interaction | BICRA interactions | 3.84e-05 | 67 | 20 | 3 | int:BICRA | |
| Interaction | GATA4 interactions | 4.15e-05 | 411 | 20 | 5 | int:GATA4 | |
| Interaction | ETV4 interactions | 4.20e-05 | 69 | 20 | 3 | int:ETV4 | |
| Interaction | RBM45 interactions | 4.60e-05 | 207 | 20 | 4 | int:RBM45 | |
| Interaction | ACE2 interactions | 6.06e-05 | 1106 | 20 | 7 | int:ACE2 | |
| Interaction | ERG interactions | 6.15e-05 | 223 | 20 | 4 | int:ERG | |
| Interaction | TRIM31 interactions | 6.65e-05 | 454 | 20 | 5 | int:TRIM31 | |
| Interaction | PHB1 interactions | 6.68e-05 | 1123 | 20 | 7 | int:PHB1 | |
| Interaction | FUS interactions | 6.79e-05 | 757 | 20 | 6 | int:FUS | |
| Interaction | RBMX interactions | 7.15e-05 | 461 | 20 | 5 | int:RBMX | |
| Interaction | BTRC interactions | 7.74e-05 | 775 | 20 | 6 | int:BTRC | |
| Interaction | SS18 interactions | 8.69e-05 | 88 | 20 | 3 | int:SS18 | |
| Interaction | SNRPA interactions | 8.83e-05 | 482 | 20 | 5 | int:SNRPA | |
| Interaction | ADCK5 interactions | 1.26e-04 | 17 | 20 | 2 | int:ADCK5 | |
| Interaction | TARDBP interactions | 1.26e-04 | 520 | 20 | 5 | int:TARDBP | |
| Interaction | BRCA1 interactions | 1.31e-04 | 1249 | 20 | 7 | int:BRCA1 | |
| Interaction | MEPCE interactions | 1.37e-04 | 859 | 20 | 6 | int:MEPCE | |
| Interaction | DCUN1D1 interactions | 1.38e-04 | 275 | 20 | 4 | int:DCUN1D1 | |
| Interaction | CNBP interactions | 1.40e-04 | 276 | 20 | 4 | int:CNBP | |
| Interaction | ARID1A interactions | 1.40e-04 | 276 | 20 | 4 | int:ARID1A | |
| Interaction | CSTF1 interactions | 1.43e-04 | 104 | 20 | 3 | int:CSTF1 | |
| Interaction | METTL14 interactions | 1.76e-04 | 558 | 20 | 5 | int:METTL14 | |
| Interaction | OBSL1 interactions | 1.78e-04 | 902 | 20 | 6 | int:OBSL1 | |
| Interaction | EWSR1 interactions | 1.83e-04 | 906 | 20 | 6 | int:EWSR1 | |
| Interaction | C9orf72 interactions | 1.84e-04 | 1319 | 20 | 7 | int:C9orf72 | |
| Interaction | FUBP3 interactions | 1.86e-04 | 297 | 20 | 4 | int:FUBP3 | |
| Interaction | CUL5 interactions | 1.89e-04 | 567 | 20 | 5 | int:CUL5 | |
| Interaction | DDX5 interactions | 1.91e-04 | 568 | 20 | 5 | int:DDX5 | |
| Interaction | TTN interactions | 1.91e-04 | 299 | 20 | 4 | int:TTN | |
| Interaction | RNU1-1 interactions | 1.94e-04 | 21 | 20 | 2 | int:RNU1-1 | |
| Interaction | HNRNPH3 interactions | 1.96e-04 | 301 | 20 | 4 | int:HNRNPH3 | |
| Interaction | SCARNA22 interactions | 2.07e-04 | 118 | 20 | 3 | int:SCARNA22 | |
| Interaction | PRMT1 interactions | 2.10e-04 | 929 | 20 | 6 | int:PRMT1 | |
| Interaction | MRPS18B interactions | 2.11e-04 | 307 | 20 | 4 | int:MRPS18B | |
| Interaction | UPF1 interactions | 2.12e-04 | 581 | 20 | 5 | int:UPF1 | |
| Interaction | HNRNPA1 interactions | 2.30e-04 | 945 | 20 | 6 | int:HNRNPA1 | |
| Interaction | OGT interactions | 2.37e-04 | 950 | 20 | 6 | int:OGT | |
| Interaction | CREBBP interactions | 2.44e-04 | 599 | 20 | 5 | int:CREBBP | |
| Interaction | GLDC interactions | 2.50e-04 | 321 | 20 | 4 | int:GLDC | |
| Interaction | SAR1A interactions | 2.62e-04 | 325 | 20 | 4 | int:SAR1A | |
| Interaction | HSF1 interactions | 2.64e-04 | 609 | 20 | 5 | int:HSF1 | |
| Interaction | BLZF1 interactions | 2.64e-04 | 128 | 20 | 3 | int:BLZF1 | |
| Interaction | EP300 interactions | 2.68e-04 | 1401 | 20 | 7 | int:EP300 | |
| Interaction | LDHB interactions | 2.68e-04 | 327 | 20 | 4 | int:LDHB | |
| Interaction | BRD7 interactions | 3.24e-04 | 637 | 20 | 5 | int:BRD7 | |
| Interaction | HNRNPD interactions | 3.27e-04 | 638 | 20 | 5 | int:HNRNPD | |
| Interaction | HLTF interactions | 3.36e-04 | 139 | 20 | 3 | int:HLTF | |
| Interaction | PHF10 interactions | 3.36e-04 | 139 | 20 | 3 | int:PHF10 | |
| Interaction | HNRNPA0 interactions | 3.44e-04 | 349 | 20 | 4 | int:HNRNPA0 | |
| Interaction | IL7R interactions | 3.50e-04 | 141 | 20 | 3 | int:IL7R | |
| Interaction | SMARCC2 interactions | 3.59e-04 | 353 | 20 | 4 | int:SMARCC2 | |
| Interaction | ITCH interactions | 3.71e-04 | 356 | 20 | 4 | int:ITCH | |
| Interaction | BMI1 interactions | 3.79e-04 | 659 | 20 | 5 | int:BMI1 | |
| Interaction | ELF5 interactions | 3.96e-04 | 147 | 20 | 3 | int:ELF5 | |
| Interaction | PPIL1 interactions | 3.96e-04 | 147 | 20 | 3 | int:PPIL1 | |
| Interaction | COX6B1 interactions | 4.20e-04 | 150 | 20 | 3 | int:COX6B1 | |
| Interaction | HNRNPAB interactions | 4.33e-04 | 371 | 20 | 4 | int:HNRNPAB | |
| Interaction | ARID2 interactions | 4.45e-04 | 153 | 20 | 3 | int:ARID2 | |
| Interaction | ZCCHC8 interactions | 4.53e-04 | 154 | 20 | 3 | int:ZCCHC8 | |
| Interaction | MCM2 interactions | 4.75e-04 | 1081 | 20 | 6 | int:MCM2 | |
| Interaction | BRCA2 interactions | 4.94e-04 | 384 | 20 | 4 | int:BRCA2 | |
| Interaction | SMARCC1 interactions | 4.94e-04 | 384 | 20 | 4 | int:SMARCC1 | |
| Interaction | CSTF2 interactions | 5.55e-04 | 165 | 20 | 3 | int:CSTF2 | |
| Interaction | LARP7 interactions | 5.55e-04 | 1113 | 20 | 6 | int:LARP7 | |
| Interaction | SYNCRIP interactions | 5.73e-04 | 721 | 20 | 5 | int:SYNCRIP | |
| Interaction | CUL4B interactions | 5.99e-04 | 728 | 20 | 5 | int:CUL4B | |
| Interaction | PIH1D1 interactions | 6.10e-04 | 731 | 20 | 5 | int:PIH1D1 | |
| Interaction | COPS6 interactions | 6.20e-04 | 408 | 20 | 4 | int:COPS6 | |
| Interaction | MDC1 interactions | 6.55e-04 | 414 | 20 | 4 | int:MDC1 | |
| Interaction | RNF8 interactions | 6.98e-04 | 421 | 20 | 4 | int:RNF8 | |
| Interaction | NKD2 interactions | 7.14e-04 | 40 | 20 | 2 | int:NKD2 | |
| Interaction | NKX2-1 interactions | 7.14e-04 | 180 | 20 | 3 | int:NKX2-1 | |
| Interaction | SOD1 interactions | 7.62e-04 | 431 | 20 | 4 | int:SOD1 | |
| Interaction | PCM1 interactions | 7.82e-04 | 434 | 20 | 4 | int:PCM1 | |
| Interaction | SNRPC interactions | 8.23e-04 | 440 | 20 | 4 | int:SNRPC | |
| Interaction | PABPN1 interactions | 8.61e-04 | 192 | 20 | 3 | int:PABPN1 | |
| Interaction | TNIP1 interactions | 8.91e-04 | 1217 | 20 | 6 | int:TNIP1 | |
| Interaction | SAFB2 interactions | 9.01e-04 | 195 | 20 | 3 | int:SAFB2 | |
| Interaction | MAPK1IP1L interactions | 9.03e-04 | 45 | 20 | 2 | int:MAPK1IP1L | |
| Interaction | DDX1 interactions | 9.95e-04 | 463 | 20 | 4 | int:DDX1 | |
| Interaction | SORBS3 interactions | 9.97e-04 | 202 | 20 | 3 | int:SORBS3 | |
| Interaction | RAB1A interactions | 1.00e-03 | 464 | 20 | 4 | int:RAB1A | |
| GeneFamily | RNA binding motif containing | 3.98e-07 | 213 | 14 | 5 | 725 | |
| GeneFamily | Zinc fingers RANBP2-type |RNA binding motif containing | 1.16e-04 | 21 | 14 | 2 | 89 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P5|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.43e-08 | 180 | 20 | 5 | 44988c34861df359a68376500c42a64fbcc4b431 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P5-P5_2|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.73e-07 | 136 | 20 | 4 | 3e13dc0634f3b05e9f9e6c3193f843f62e603b78 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P5-P5_2-Sox4|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.73e-07 | 136 | 20 | 4 | 0185486c39700dd2f72d79be6d283494dd8379c9 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.36e-06 | 188 | 20 | 4 | 8bd6f2cd1aadbd6f9ed31b160f59c1eff144e1dc | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.29e-05 | 184 | 20 | 3 | bd786db4dc4edae6d5cfc0b69901983dea19f729 | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 7.53e-05 | 186 | 20 | 3 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 7.53e-05 | 186 | 20 | 3 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | ASK428-Immune-NK_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 8.02e-05 | 190 | 20 | 3 | d649f7e17c4227787465dfc02037f791ff85378b | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW13-Stem_cells|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 9.19e-05 | 199 | 20 | 3 | fd1d1b95e01719e3d0a17d9d1f29717a47209d32 | |
| ToppCell | megakaryocytic-CD34+_Megakaryoblast|megakaryocytic / Lineage and Cell class | 9.19e-05 | 199 | 20 | 3 | 99a65887d3c8a2cde26693dd74404b101bba9d58 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW13-Stem_cells-Stem_cells|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 9.19e-05 | 199 | 20 | 3 | 91882af9dc7265c9b419f4415cbcf656087a2ab3 | |
| ToppCell | HSPCs|World / Lineage and Cell class | 9.19e-05 | 199 | 20 | 3 | df1ffc416c6946f1ba182f242a50ee41a571d565 | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-H|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 9.33e-05 | 200 | 20 | 3 | 0ebc54d19873a2b7b6d12b81559cb12abd73b90c | |
| Computational | Neighborhood of CDK2 | 1.24e-04 | 72 | 15 | 3 | MORF_CDK2 | |
| Computational | Neighborhood of FBL | 8.77e-04 | 140 | 15 | 3 | MORF_FBL | |
| Computational | Neighborhood of PTK2 | 9.71e-04 | 145 | 15 | 3 | GCM_PTK2 | |
| Computational | Neighborhood of TDG | 1.05e-03 | 35 | 15 | 2 | GNF2_TDG | |
| Computational | Neighborhood of PSMC1 | 2.11e-03 | 190 | 15 | 3 | MORF_PSMC1 | |
| Computational | Neighborhood of RAN | 2.31e-03 | 196 | 15 | 3 | GCM_RAN | |
| Computational | Neighborhood of ANP32B | 2.38e-03 | 198 | 15 | 3 | MORF_ANP32B | |
| Computational | Neighborhood of AATF | 2.77e-03 | 209 | 15 | 3 | MORF_AATF | |
| Computational | Neighborhood of DEK | 2.87e-03 | 58 | 15 | 2 | GNF2_DEK | |
| Computational | Neighborhood of ESPL1 | 3.17e-03 | 61 | 15 | 2 | MORF_ESPL1 | |
| Computational | Neighborhood of TERF1 | 3.81e-03 | 67 | 15 | 2 | MORF_TERF1 | |
| Computational | Neighborhood of XRCC5 | 3.86e-03 | 235 | 15 | 3 | MORF_XRCC5 | |
| Computational | Neighborhood of UBE2I | 4.00e-03 | 238 | 15 | 3 | MORF_UBE2I | |
| Computational | Genes in the cancer module 32. | 4.15e-03 | 241 | 15 | 3 | MODULE_32 | |
| Computational | Neighborhood of HDAC1 | 4.81e-03 | 254 | 15 | 3 | MORF_HDAC1 | |
| Computational | Neighborhood of DEK | 5.35e-03 | 264 | 15 | 3 | MORF_DEK | |
| Computational | Neighborhood of RAN | 5.58e-03 | 268 | 15 | 3 | MORF_RAN | |
| Computational | Neighborhood of PCNA | 5.79e-03 | 83 | 15 | 2 | MORF_PCNA | |
| Computational | Neighborhood of BUB3 | 6.12e-03 | 277 | 15 | 3 | MORF_BUB3 | |
| Drug | 2d41 | 1.67e-06 | 27 | 20 | 3 | CID009543496 | |
| Drug | A-skin | 2.83e-06 | 32 | 20 | 3 | CID000208772 | |
| Drug | 12-mo | 4.42e-06 | 37 | 20 | 3 | CID000001420 | |
| Drug | thymine glycol | 1.11e-05 | 50 | 20 | 3 | CID000018058 | |
| Drug | Baclofen (R,S) [1134-47-0]; Down 200; 18.8uM; HL60; HG-U133A | 2.32e-05 | 196 | 20 | 4 | 2036_DN | |
| Drug | Carcinine [56897-53-1]; Down 200; 22uM; MCF7; HT_HG-U133A | 2.41e-05 | 198 | 20 | 4 | 4809_DN | |
| Drug | O-(biotinylcarbazoylmethyl) hydroxylamine | 2.63e-05 | 9 | 20 | 2 | CID000083922 | |
| Drug | R A J | 3.61e-05 | 74 | 20 | 3 | CID011497471 | |
| Drug | tempol | 3.70e-05 | 221 | 20 | 4 | CID000137994 | |
| Drug | AC1NRAYK | 4.01e-05 | 11 | 20 | 2 | CID005288161 | |
| Drug | thiodiglycol | 4.01e-05 | 11 | 20 | 2 | CID000005447 | |
| Drug | cytosine glycol | 4.81e-05 | 12 | 20 | 2 | CID000166830 | |
| Drug | caryophyllene | 6.63e-05 | 14 | 20 | 2 | ctd:C024714 | |
| Drug | L-anserine | 8.73e-05 | 16 | 20 | 2 | CID000011444 | |
| Drug | berberine | 9.29e-05 | 280 | 20 | 4 | CID000002353 | |
| Drug | Pilocarpine | 9.94e-05 | 285 | 20 | 4 | ctd:D010862 | |
| Drug | Acetic Acid | 1.03e-04 | 105 | 20 | 3 | ctd:D019342 | |
| Drug | Endocrine Disruptors | 1.18e-04 | 110 | 20 | 3 | ctd:D052244 | |
| Drug | MPCA | 1.83e-04 | 23 | 20 | 2 | CID000031060 | |
| Drug | 8-oxyguanine | 1.93e-04 | 130 | 20 | 3 | CID000119315 | |
| Drug | POBN | 2.17e-04 | 25 | 20 | 2 | CID000092375 | |
| Drug | Trichlorfon | 2.17e-04 | 25 | 20 | 2 | ctd:D014236 | |
| Drug | HMdU | 2.17e-04 | 25 | 20 | 2 | CID000091541 | |
| Drug | 5'-TG-3 | 2.35e-04 | 26 | 20 | 2 | CID000482133 | |
| Drug | dialuric acid | 2.35e-04 | 26 | 20 | 2 | CID000067956 | |
| Drug | benzo(a)pyrene | 2.39e-04 | 358 | 20 | 4 | CID000002336 | |
| Drug | 2H1H | 2.73e-04 | 28 | 20 | 2 | CID011527397 | |
| Drug | 8-hydroxyadenine | 2.73e-04 | 28 | 20 | 2 | CID005355054 | |
| Drug | Citric Acid | 2.93e-04 | 29 | 20 | 2 | ctd:D019343 | |
| Drug | O-Nb | 3.14e-04 | 30 | 20 | 2 | CID000006829 | |
| Drug | AC1L1AUZ | 3.36e-04 | 157 | 20 | 3 | CID000001160 | |
| Drug | 8-oxoG | 3.58e-04 | 32 | 20 | 2 | CID000065131 | |
| Drug | FapyAde | 3.81e-04 | 33 | 20 | 2 | CID000114926 | |
| Drug | EMCs | 4.04e-04 | 34 | 20 | 2 | CID005091655 | |
| Drug | hafnium oxide | 4.29e-04 | 35 | 20 | 2 | CID000292779 | |
| Drug | profenofos | 4.54e-04 | 36 | 20 | 2 | ctd:C024273 | |
| Drug | AC1NRA5C | 4.54e-04 | 174 | 20 | 3 | CID005287709 | |
| Drug | histidinate | 4.54e-04 | 174 | 20 | 3 | CID000000773 | |
| Drug | 14-deoxy-11,12-didehydroandrographolide | 4.62e-04 | 175 | 20 | 3 | ctd:C495626 | |
| Drug | allantoin | 4.79e-04 | 37 | 20 | 2 | CID000000204 | |
| Drug | Nivalenol hydrate | 5.06e-04 | 38 | 20 | 2 | CID000031829 | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 5.35e-04 | 184 | 20 | 3 | 2321_DN | |
| Drug | nitroxyl | 5.43e-04 | 185 | 20 | 3 | CID000000945 | |
| Drug | AC1L1B55 | 5.87e-04 | 454 | 20 | 4 | CID000001287 | |
| Drug | PF-00562151-00 [351320-12-2]; Down 200; 10uM; MCF7; HT_HG-U133A | 5.87e-04 | 190 | 20 | 3 | 6912_DN | |
| Drug | retinoic acid; Down 200; 1uM; MCF7; HT_HG-U133A | 5.87e-04 | 190 | 20 | 3 | 1636_DN | |
| Drug | sivelestat | 5.89e-04 | 41 | 20 | 2 | CID000107706 | |
| Drug | 0297417-0002B [362658-29-5]; Down 200; 10uM; MCF7; HT_HG-U133A | 5.96e-04 | 191 | 20 | 3 | 6900_DN | |
| Drug | Diphenylpyraline hydrochloride [132-18-3]; Down 200; 12.6uM; PC3; HT_HG-U133A | 5.96e-04 | 191 | 20 | 3 | 4299_DN | |
| Drug | PNU-0293363 [326823-19-2]; Up 200; 10uM; MCF7; HT_HG-U133A | 6.05e-04 | 192 | 20 | 3 | 6573_UP | |
| Drug | 2-propylpentanoic acid; Down 200; 50uM; MCF7; HT_HG-U133A | 6.05e-04 | 192 | 20 | 3 | 1647_DN | |
| Drug | Oxolinic acid [14698-29-4]; Down 200; 15.4uM; HL60; HG-U133A | 6.05e-04 | 192 | 20 | 3 | 1419_DN | |
| Drug | CP-690334-01 [459212-38-5]; Down 200; 10uM; MCF7; HT_HG-U133A | 6.15e-04 | 193 | 20 | 3 | 3906_DN | |
| Drug | Fusidic Acid-d6 | 6.18e-04 | 42 | 20 | 2 | CID000003443 | |
| Drug | PM 2 | 6.18e-04 | 42 | 20 | 2 | CID000657077 | |
| Drug | Azaguanine-8 [134-58-7]; Down 200; 26.2uM; MCF7; HT_HG-U133A | 6.24e-04 | 194 | 20 | 3 | 1670_DN | |
| Drug | Graveoline [485-61-0]; Down 200; 14.4uM; MCF7; HT_HG-U133A | 6.24e-04 | 194 | 20 | 3 | 4738_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 6.24e-04 | 194 | 20 | 3 | 5017_DN | |
| Drug | Captopril [62571-86-2]; Down 200; 17.2uM; HL60; HG-U133A | 6.24e-04 | 194 | 20 | 3 | 1988_DN | |
| Drug | Bepridil hydrochloride [74764-40-2]; Up 200; 10uM; HL60; HT_HG-U133A | 6.24e-04 | 194 | 20 | 3 | 1274_UP | |
| Drug | Domperidone maleate; Down 200; 7.4uM; MCF7; HT_HG-U133A | 6.24e-04 | 194 | 20 | 3 | 2655_DN | |
| Drug | Sulindac [38194-50-2]; Up 200; 11.2uM; PC3; HT_HG-U133A | 6.33e-04 | 195 | 20 | 3 | 1815_UP | |
| Drug | Chlorpropamide [94-20-2]; Down 200; 14.4uM; MCF7; HT_HG-U133A | 6.33e-04 | 195 | 20 | 3 | 3210_DN | |
| Drug | Benfluorex hydrochloride [23642-66-2]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 6.33e-04 | 195 | 20 | 3 | 5327_DN | |
| Drug | Disopyramide [3737-09-5]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 6.33e-04 | 195 | 20 | 3 | 7035_DN | |
| Drug | pioglitazone HCl; Down 200; 10uM; MCF7; HT_HG-U133A | 6.43e-04 | 196 | 20 | 3 | 7083_DN | |
| Drug | Orlistat; Down 200; 10uM; MCF7; HT_HG-U133A | 6.43e-04 | 196 | 20 | 3 | 6905_DN | |
| Drug | 16, 16-dimethylprostaglandin E2 methyl acetate solution; Down 200; 10uM; PC3; HT_HG-U133A | 6.43e-04 | 196 | 20 | 3 | 6562_DN | |
| Drug | Letrozole [112809-51-5]; Up 200; 14uM; MCF7; HT_HG-U133A | 6.43e-04 | 196 | 20 | 3 | 4824_UP | |
| Drug | EF-T | 6.48e-04 | 43 | 20 | 2 | CID003054237 | |
| Drug | Desipramine hydrochloride [58-28-6]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 6.52e-04 | 197 | 20 | 3 | 5292_DN | |
| Drug | Butirosin disulfate salt [51022-98-1]; Down 200; 5.4uM; HL60; HT_HG-U133A | 6.52e-04 | 197 | 20 | 3 | 2518_DN | |
| Drug | SB 202190; Down 200; 1uM; MCF7; HT_HG-U133A | 6.52e-04 | 197 | 20 | 3 | 6909_DN | |
| Drug | 5194442; Down 200; 20uM; MCF7; HT_HG-U133A | 6.52e-04 | 197 | 20 | 3 | 6558_DN | |
| Drug | Cephapirin sodium salt [24356-60-3]; Down 200; 9uM; MCF7; HT_HG-U133A | 6.62e-04 | 198 | 20 | 3 | 6790_DN | |
| Drug | Zidovudine, AZT [30516-87-1]; Down 200; 15uM; HL60; HG-U133A | 6.62e-04 | 198 | 20 | 3 | 1595_DN | |
| Drug | novobiocin sodium, USP; Down 200; 100uM; MCF7; HG-U133A | 6.62e-04 | 198 | 20 | 3 | 576_DN | |
| Drug | Biperiden hydrochloride [1235-82-1]; Up 200; 11.4uM; HL60; HT_HG-U133A | 6.62e-04 | 198 | 20 | 3 | 2460_UP | |
| Drug | Decamethonium bromide [541-22-0]; Down 200; 9.6uM; HL60; HT_HG-U133A | 6.72e-04 | 199 | 20 | 3 | 2933_DN | |
| Drug | Molindone hydrochloride [15622-65-8]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 6.72e-04 | 199 | 20 | 3 | 7337_DN | |
| Drug | Moroxidine hydrochloride [3160-91-6]; Down 200; 19.2uM; HL60; HG-U133A | 6.82e-04 | 200 | 20 | 3 | 2027_DN | |
| Drug | formamidopyrimidine | 7.09e-04 | 45 | 20 | 2 | CID000535165 | |
| Drug | AC1L97HB | 7.09e-04 | 45 | 20 | 2 | CID000439504 | |
| Drug | AC1LA6XC | 7.09e-04 | 45 | 20 | 2 | CID000482573 | |
| Drug | o-nitrophenyl beta-glucoside | 8.07e-04 | 48 | 20 | 2 | CID000092941 | |
| Drug | D-salicin | 8.41e-04 | 49 | 20 | 2 | CID000005145 | |
| Drug | N-tert-butyl-a-phenylnitrone | 8.41e-04 | 49 | 20 | 2 | CID000004390 | |
| Drug | Nor 3 | 8.76e-04 | 50 | 20 | 2 | CID009578441 | |
| Drug | 8-oxo-dGTP | 8.76e-04 | 50 | 20 | 2 | CID000107902 | |
| Drug | 2,3,6-TBA | 8.76e-04 | 50 | 20 | 2 | CID000005759 | |
| Disease | amyotrophic lateral sclerosis type 6 (implicated_via_orthology) | 1.31e-06 | 3 | 20 | 2 | DOID:0060198 (implicated_via_orthology) | |
| Disease | frontotemporal dementia (implicated_via_orthology) | 2.87e-05 | 12 | 20 | 2 | DOID:9255 (implicated_via_orthology) | |
| Disease | Nephrotic Syndrome | 1.52e-04 | 27 | 20 | 2 | C0027726 | |
| Disease | gastric adenocarcinoma (is_marker_for) | 1.63e-04 | 28 | 20 | 2 | DOID:3717 (is_marker_for) | |
| Disease | amyotrophic lateral sclerosis (implicated_via_orthology) | 1.88e-04 | 30 | 20 | 2 | DOID:332 (implicated_via_orthology) | |
| Disease | hepatocellular carcinoma (is_implicated_in) | 2.40e-04 | 181 | 20 | 3 | DOID:684 (is_implicated_in) | |
| Disease | Malignant neoplasm of breast | 6.22e-04 | 1074 | 20 | 5 | C0006142 | |
| Disease | Amyotrophic Lateral Sclerosis | 7.05e-04 | 58 | 20 | 2 | C0002736 | |
| Disease | Cholestasis | 2.50e-03 | 110 | 20 | 2 | C0008370 | |
| Disease | Malignant Neoplasms | 3.37e-03 | 128 | 20 | 2 | C0006826 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PGYEAAYGGAYGENP | 336 | Q13569 | |
| LGEGVPPGNYGNYGY | 6 | O15155 | |
| PPGNYGNYGYANSGY | 11 | O15155 | |
| GGYNQPSLGYGQSNY | 156 | Q01844 | |
| GGPGTYQYSQGAPLY | 226 | O95936 | |
| DNQGGAPNYYPNSFG | 396 | P04040 | |
| QPDFPYGQYAGYGQD | 341 | Q96EP5 | |
| GGGQYFAKPQNQGGY | 291 | Q32P51 | |
| YGPQGGQYGPQGGYP | 796 | O14497 | |
| GQQEGAPSFPTGYQY | 96 | Q9UGV2 | |
| RGLTGNYYPGPGNYG | 156 | Q3ZCV2 | |
| NYYPGPGNYGEKGNP | 161 | Q3ZCV2 | |
| TQSYGAYPTQPGQGY | 11 | P35637 | |
| YQGNGDYGSYAPAAP | 216 | Q14678 | |
| SQYYPLGQSEGDGGY | 96 | P14653 | |
| GGPNNGGYDDDQGSY | 196 | Q92630 | |
| SYSQPPYNQGGYSQG | 756 | Q9BUJ2 | |
| GYGPQDSYGPQGGYQ | 261 | P08247 | |
| DSYGPQGGYQPDYGQ | 266 | P08247 | |
| GSGYGPQGDYGQQGY | 286 | P08247 | |
| PQGDYGQQGYGPQGA | 291 | P08247 | |
| WNQGYGYQQGYGPGY | 276 | Q99729 | |
| GPQDAQEYGNYQPGS | 611 | P23327 | |
| QGYPGQQQGYGPSQG | 356 | Q15532 | |
| QSQQSYDYGGSGGPY | 21 | Q969M3 | |
| QGYREPCGVPNGGYY | 596 | Q63HR2 |